Obstructive sleep apnoe and cardiovascular, heart failure and mortality outcomes with empagliflozin versus placebo in the EMPA-REG OUTCOME trial

被引：0

作者：

Yaggi, H. K. ^{[1
]}

Eliasson, B. ^{[2
]}

Kasai, T. ^{[3
]}

Marx, N. ^{[4
]}

Zinman, B. ^{[5
]}

Inzucchi, S. E. ^{[1
]}

Wanner, C. ^{[6
]}

Zwiener, I ^{[7
]}

Wojeck, B. ^{[1
]}

Neeland, I ^{[8
]}

Johansen, O. ^{[9
]}

机构：

[1] Yale Univ, Yale Sch Med, New Haven, CT USA

[2] Sahlgrens Acad, Gothenburg, Sweden

[3] Juntendo Univ, Dept Cardiovasc Med, Grad Sch Med, Tokyo, Japan

[4] RWTH Univ Hosp Aachen, Aachen, Germany

[5] Univ Hlth Network, Mt Sinai Hosp, Toronto, ON, Canada

[6] Univ Hosp Wurzburg, Wurzburg, Germany

[7] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany

[8] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA

[9] Boehringer Ingelheim GmbH & Co KG, Hovik, Norway

来源：

EUROPEAN HEART JOURNAL | 2020年 / 41卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2883 / 2883

页数：1

共 50 条

[1] Obstructive Sleep Apnoe and Cardiovascular, Heart Failure and Mortality Outcomes with Empagliflozin Versus Placebo in the EMPA-REG Outcome®Trial
Yaggi, H. K.
Eliasson, B.
Kasai, T.
Marx, N.
Zinman, B.
Inzucchi, S. S. E.
Wanner, C.
Zwiener, I.
Wojeck, B.
Neeland, I. J.
Johansen, O.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
[2] Retinopathy Outcomes With Empagliflozin Versus Placebo in the EMPA-REG OUTCOME Trial
Inzucchi, Silvio E.
Wanner, Christoph
Hehnke, Uwe
Zwiener, Isabella
Kaspers, Stefan
Clark, Douglas
George, Jyothis T.
Zinman, Bernard
DIABETES CARE, 2019, 42 (04) : E53 - E55
[3] Mediators of the Improvement in Heart Failure Outcomes With Empagliflozin in the EMPA-REG OUTCOME Trial
Fitchett, David
Inzucchi, Silvio E.
Zinman, Bernard
Wanner, Christoph
Zannad, Faiez
Schumacher, Martin
Schmoor, Claudia
Ohneberg, Kristin
Salsali, Afshin
George, Jyothis T.
Hantel, Stefan
Bluhmki, Erich
Lachin, John M.
CIRCULATION, 2017, 136
[4] Mediators of the improvement in heart failure outcomes with empagliflozin in the EMPA-REG OUTCOME trial
Fitchett, David
Inzucchi, Silvio E.
Zinman, Bernard
Wanner, Christoph
Schumacher, Martin
Schmoor, Claudia
Ohneberg, Kristin
Ofstad, Anne Pernille
Salsali, Afshin
George, Jyothis T.
Hantel, Stefan
Bluhmki, Erich
Lachin, John M.
Zannad, Faiez
ESC HEART FAILURE, 2021, 8 (06): : 4517 - 4527
[5] Mediators of the improvement in heart failure outcomes with empagliflozin in the EMPA-REG OUTCOME trial
Fitchett, David
Inzucchi, Silvio E.
Zinman, Bernard
Wanner, Christoph
Schumacher, Martin
Schmoor, Claudia
Ohneberg, Kristin
Ofstad, Anne Pernille
Salsali, Afshin
George, Jyothis T.
Hantel, Stefan
Bluhmki, Erich
Lachin, John M.
Zannad, Faiez
ESC HEART FAILURE, 2022, 8 (06): : 4517 - 4527
[6] The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial
Neeland, Ian J.
Eliasson, Bjorn
Kasai, Takatoshi
Marx, Nikolaus
Zinman, Bernard
Inzucchi, Silvio E.
Wanner, Christoph
Zwiener, Isabella
Wojeck, Brian S.
Yaggi, Henry K.
Johansen, Odd Erik
DIABETES CARE, 2020, 43 (12) : 3007 - 3015
[7] Empagliflozin and obstructive sleep apnoea: exploratory analysis from the EMPA-REG OUTCOME trial
Neeland, I. J.
Eliasson, B.
Kasai, T.
Marx, N.
Zinman, B.
Inzucchi, S. E.
Wanner, C.
Zwiener, I.
Wojeck, B.
Yaggi, H.
Johansen, O.
DIABETOLOGIA, 2020, 63 (SUPPL 1) : S463 - S464
[8] Composite retinopathy outcome in patients treated with empagliflozin versus placebo in the EMPA-REG OUTCOME trial
Inzucchi, S. E.
Wanner, C.
Hehnke, U.
Lee, J.
Kaspers, S.
Clark, D.
George, J. T.
Zinman, B.
DIABETOLOGIA, 2018, 61 : S300 - S300
[9] Empagliflozin and Microvascular Outcomes in EMPA-REG Outcome
Wanner, Christoph
Lee, Christopher
Woerle, Hans J.
Mattheus, Michaela
Inzucchi, Silvio E.
Zinman, Bernard
DIABETES, 2016, 65 : A283 - A283
[10] Empagliflozin and microvascular outcomes in EMPA-REG OUTCOME
Wanner, C.
Lee, C.
Woerle, H. -J.
Mattheus, M.
Inzucchi, S. E.
Zinman, B.
DIABETOLOGIA, 2016, 59 : S483 - S484

← 1 2 3 4 5 →